Chip equipment stocks reverse as report says China mass-produces domestic DUV machines

3 min read
Chip equipment stocks reverse as report says China mass-produces domestic DUV machines
PrimeXBT Editorial Team
Reviewed by PrimeXBT

Topics in article

Semiconductor capital equipment shares swung from a pre-market high to a sharp sell-off on Monday after The Information reported that a Shanghai-based, state-backed company has started mass-producing homegrown immersion DUV lithography machines. ASML, Applied Materials, Lam Research and KLA Corp were all down roughly 7% at their intraday lows. Analysts at BofA, JPMorgan and BNP Paribas then argued the reaction went too far, and the stocks pared losses into the close.

Semiconductor capital equipment stocks took a U-turn on Monday, swinging from AI-driven euphoria to geopolitical panic in a matter of hours. At their intraday lows, ASML, Applied Materials, Lam Research and KLA Corp were all down roughly 7%. The synchronized sell-off wiped billions from the sector's market value within minutes.

The trigger was a report from The Information: a Shanghai-based, state-backed company, incorporating teams from startups such as Yuliangsheng Technology, has started mass-producing homegrown immersion DUV lithography machines. It intends to produce 5 DUV tools this year and 20 next year for domestic customers including SMIC, CXMT and Hua Hong.

Washington's MATCH Act meets a domestic Chinese tool

Before that headline, the sector was riding a pre-market high on easing geopolitical tensions in Iran and a Wall Street Journal report that Nvidia is in talks to guarantee $250 billion in financing for an OpenAI data center project. That momentum evaporated instantly.

The report arrives as the U.S. Congress advances the MATCH Act, legislation aimed at blocking China from buying or servicing these exact DUV machines. If China can build them domestically, impending U.S. restrictions may lose their teeth entirely. The market's initial logic ran down the rest of the chain: if Chinese engineering has conquered the lithography bottleneck, deposition, etching and inspection are highly vulnerable to replacement too.

Losses narrow into the final hour

Bleeding slowed as trading entered the final hour. ASML traded down 5.75%, and Applied Materials was down 4% heading into the close. Lam Research was off 4.5% and KLA Corp traded down 3%.

Wall Street analysts drove the afternoon recovery, arguing that the market is conflating a prototype milestone with an imminent commercial threat.

Analysts push back on the panic

BofA's Didier Scemama reiterated a Buy rating and a €2,452 price target, calling the threat to ASML modest because China's leading domestic player, SMEE, has yet to demonstrate high-volume production at 28nm or below. According to BofA, in leading-edge Chinese manufacturing "even modest reductions in scanner performance could materially lower yields and increase cost per die" — and ASML's NXT:1980Fi already delivers 330 wafers per hour.

Scemama calculated that even if China sources 20 domestic tools next year, ASML sales would drop by an estimated €1.4 billion, or 2.4% of projected group sales. JPMorgan's Sandeep Deshpande called the reaction disproportionate, stressing that yield, overlay, throughput and reliability over thousands of wafer runs are what matter. He acknowledged long-term risks to ASML's China revenue while calling mid-term earnings intact.

BNP Paribas' Jakob Bluestone framed the development as a small negative, pointing out that ASML's demand far outstrips its available supply. DRAM capacity growth in China alone is projected to add more than 500,000 wafer starts per month before 2030, a scale-up requiring several hundred ArFi tools. On that arithmetic, Bluestone argued, local Chinese lithography manufacturing is a likely necessity rather than a total replacement of ASML's business.

Source: Investing.com

Trading involves risk.

Most traded markets

XAU / USD
-0.9% 4,127.61
BRENT
+1.35% 73.620
BTC / USD
+0.7% 63,151.2
EUR / USD
-0.12% 1.14269
USTEC
-0.91% 29,428.7
XAU / USD.24
-0.9% 4,127.61
View all markets

Author

PrimeXBT
Our Editorial Team consists of leading experts with a proven record in the fields of trading, cryptocurrencies, blockchain and finance. We thoroughly research the sources of information in order to provide readers with quality content that serves edu...
Read author’s articles
Alert Triangle Risk Disclaimer
Disclaimer: Some past publications may be outdated. We recommend following our news to stay up to date with the latest information. For any questions, feel free to contact our support team via the chat below.
The content provided here is for informational purposes only. It is not intended as personal investment advice and does not constitute a solicitation or invitation to engage in any financial transactions, investments, or related activities. Past performance is not a reliable indicator of future results.
The financial products offered by the Company are complex and come with a high risk of losing money rapidly due to leverage. These products may not be suitable for all investors. Before engaging, you should consider whether you understand how these leveraged products work and whether you can afford the high risk of losing your money.
The Company does not accept clients from the Restricted Jurisdictions as indicated in our website/ T&C. Some services or products may not be available in your jurisdiction.
The applicable legal entity and its respective products and services depend on the client’s country of residence and the entity with which the client has established a contractual relationship during registration.

Today in markets

Browse Indices News

Register Now

Trading involves risk

Get started in minutes

Our clients love how fast and simple our sign-up is. It takes just a few minutes to get started!

Get Started Get Started
Get started in minutes

Need Help?

Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.